Pluri Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Pluri Inc. (PLUR) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of -$167.00 thousand for the 6-month period ending 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2014-02-05
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-12-31 was -$327.00K.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-09-30 was $160.00K, a 433.33% increase year-over-year.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-06-30 was -$56.00K, a 106.18% decline year-over-year.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2013-03-31 was $1.66M, a 3099.20% increase year-over-year.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $1.56M, a 62.42% increase from fiscal 2012.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $958.00K, a 155.47% increase from fiscal 2011.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $375.00K, a 212.50% increase from fiscal 2010.
- Pluri Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2010 was $120.00K.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | -$327.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | -$167.00K 10-Q · filed 2014-02-05 | -$223.00K derived: sum of 3 quarters · filed 2014-02-05 | $1.44M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2013-09-30 | $160.00K 10-Q · filed 2013-11-05 | $104.00K derived: sum of 2 quarters · filed 2013-11-05 | $1.76M derived: sum of 3 quarters · filed 2013-11-05 | $1.69M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2013-06-30 | -$56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $1.60M derived: sum of 2 quarters · filed 2013-09-11 | $1.53M derived: sum of 3 quarters · filed 2014-02-05 | $1.56M 10-K · filed 2013-09-11 | |
| 2013-03-31 | $1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $1.58M derived: sum of 2 quarters · filed 2014-02-05 | $1.61M 10-Q · filed 2013-05-08 | $2.52M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2012-12-31 | -$78.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | -$48.00K 10-Q · filed 2014-02-05 | -$48.00 10-Q · filed 2013-01-31 | $858.00K derived: sum of 3 quarters · filed 2014-02-05 | $909.89K derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-09-30 | $30.00K 10-Q · filed 2013-11-05 | $936.00K derived: sum of 2 quarters · filed 2013-11-05 | $987.89K derived: sum of 3 quarters · filed 2013-11-05 | $783.00K derived: sum of 4 quarters · filed 2013-11-05 | |
| 2012-06-30 | $906.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $957.89K derived: sum of 2 quarters · filed 2013-09-11 | $753.00K derived: sum of 3 quarters · filed 2013-09-11 | $958.00K 10-K · filed 2013-09-11 | |
| 2012-03-31 | $51.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | -$153.00K derived: sum of 2 quarters · filed 2013-05-08 | $52.00K 10-Q · filed 2013-05-08 | $271.00K derived: sum of 4 quarters · filed 2013-09-11 | |
| 2011-12-31 | -$204.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $112.00 10-Q · filed 2013-01-31 | $112.00K 10-Q · filed 2012-02-09 | $219.11K derived: sum of 3 quarters · filed 2013-09-11 | $341.11K derived: sum of 4 quarters · filed 2013-09-11 |
| 2011-09-30 | $205.00K 10-Q · filed 2012-11-06 | $424.00K derived: sum of 2 quarters · filed 2013-09-11 | $546.00K derived: sum of 3 quarters · filed 2013-09-11 | $547.00K derived: sum of 4 quarters · filed 2013-09-11 | |
| 2011-06-30 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $341.00K derived: sum of 2 quarters · filed 2013-09-11 | $342.00K derived: sum of 3 quarters · filed 2013-09-11 | $375.00K 10-K · filed 2013-09-11 | |
| 2011-03-31 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-05-08 | $123.00K derived: sum of 2 quarters · filed 2012-05-08 | $156.00K 10-Q · filed 2012-05-08 | ||
| 2010-12-31 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-02-09 | $34.00K 10-Q · filed 2012-02-09 | |||
| 2010-09-30 | $33.00K 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $120.00K 10-K · filed 2012-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |